← Leaderboards
Hong W Chu
National Jewish Health
$18,238,701
Attributed
$26,553,445
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,553,445 · 13
By mechanism
R01$20,439,042 · 9
U19$3,285,890 · 2
P01$2,358,013 · 1
R21$470,500 · 1
Top collaborators
- Yuanpu Peter Di5 shared
- Fernando Holguin5 shared
- Liwu Li5 shared
- Raymond B. Penn5 shared
- Max A Seibold5 shared
- Linda F Van Dyk5 shared
- Julia K L Walker5 shared
- Irina Petrache4 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Lisa A Maier$11,952,941
- Ivana V Yang$13,155,768
- Brian J Day$12,321,853
- Dennis R Voelker$17,845,148
- Richard J Martin$13,509,122
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungEpithelial CellsCytokineAsthmaInterleukin-13InflammationAirway InflammationAirway EpitheliumInflammatoryProductionAsthmaticSignal TransductionMediatingAllergensMouse ModelInfectionLung DiseasesIn VivoKnockout MiceRhinovirusAcuteNeutrophilVirus DiseasesCell Culture Techniques
Grant awards (58)
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$629,899
R01 · FY2025 · AI
Tollip inhibits IL-33 signaling during airway influenza virus infection$287,585
U19 · FY2025 · AI · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$712,997
R01 · FY2024 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$629,899
R01 · FY2024 · AI
Role of immunoproteasome in airway viral infection$555,914
R01 · FY2024 · AI · contact PI
The Role of Airway Epithelial Complement in Chronic Beryllium Disease$470,500
R21 · FY2024 · ES
Tollip inhibits IL-33 signaling during airway influenza virus infection$461,758
U19 · FY2024 · AI · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$718,437
R01 · FY2023 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$629,899
R01 · FY2023 · AI
Role of immunoproteasome in airway viral infection$555,914
R01 · FY2023 · AI · contact PI
Tollip inhibits IL-33 signaling during airway influenza virus infection$253,380
U19 · FY2023 · AI · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$729,236
R01 · FY2022 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$615,316
R01 · FY2022 · AI
Role of immunoproteasome in airway viral infection$555,914
R01 · FY2022 · AI · contact PI
Tollip inhibits IL-33 signaling during airway influenza virus infection$284,387
U19 · FY2022 · AI · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$731,404
R01 · FY2021 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$661,553
R01 · FY2021 · AI
Role of immunoproteasome in airway viral infection$563,195
R01 · FY2021 · AI · contact PI
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$465,888
R01 · FY2021 · HL · contact PI
Tollip inhibits IL-33 signaling during airway influenza virus infection$332,617
U19 · FY2021 · AI · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$771,182
R01 · FY2020 · AI · contact PI
Role of immunoproteasome in airway viral infection$579,669
R01 · FY2020 · AI · contact PI
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$474,847
R01 · FY2020 · HL · contact PI
Role of Tollip in dysfunction of asthma airway innate immunity$317,000
U19 · FY2020 · AI · contact PI
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$483,551
R01 · FY2019 · HL · contact PI
Role of Tollip in dysfunction of asthma airway innate immunity$317,000
U19 · FY2019 · AI · contact PI
SPLUNC1 in Severe Asthma$490,516
R01 · FY2018 · HL
Immunosuppressive injurious effects of e-cigarettes on human lung parenchyma$487,000
R01 · FY2018 · HL · contact PI
IRAK-M in lung defense against rhinovirus infection$398,037
R01 · FY2018 · AI · contact PI
Novel function of MUC18: amplification of inflammation in allergic lungs$396,250
R01 · FY2018 · HL · contact PI
Role of Tollip in dysfunction of asthma airway innate immunity$315,908
U19 · FY2018 · AI · contact PI
SPLUNC1 in Severe Asthma$490,516
R01 · FY2017 · HL
IRAK-M in lung defense against rhinovirus infection$398,037
R01 · FY2017 · AI · contact PI
Novel function of MUC18: amplification of inflammation in allergic lungs$396,250
R01 · FY2017 · HL · contact PI
Role of Tollip in dysfunction of asthma airway innate immunity$317,000
U19 · FY2017 · AI · contact PI
SPLUNC1 in Severe Asthma$490,516
R01 · FY2016 · HL
IRAK-M in lung defense against rhinovirus infection$399,799
R01 · FY2016 · AI · contact PI
Role of Tollip in dysfunction of asthma airway innate immunity$399,255
U19 · FY2016 · AI · contact PI
Novel function of MUC18: amplification of inflammation in allergic lungs$396,250
R01 · FY2016 · HL · contact PI
SPLUNC1 in Severe Asthma$44,401
R01 · FY2016 · HL
SPLUNC1 in Severe Asthma$405,084
R01 · FY2015 · HL
IRAK-M in lung defense against rhinovirus infection$404,458
R01 · FY2015 · AI · contact PI
Novel function of MUC18: amplification of inflammation in allergic lungs$396,250
R01 · FY2015 · HL · contact PI
IRAK-M in lung defense against rhinovirus infection$419,028
R01 · FY2014 · AI · contact PI
SPLUNC1 protein in host defense against Mycoplasma pneumoniae infection$386,100
R01 · FY2012 · HL · contact PI
SPLUNC1 protein in host defense against Mycoplasma pneumoniae infection$390,000
R01 · FY2011 · HL · contact PI
Effects of Allergic Inflammation on TLR2 Signaling and Mycoplasma Infection$386,100
R01 · FY2011 · AI · contact PI
SPLUNC1 protein in host defense against Mycoplasma pneumoniae infection$390,000
R01 · FY2010 · HL · contact PI
Effects of Allergic Inflammation on TLR2 Signaling and Mycoplasma Infection$386,100
R01 · FY2010 · AI · contact PI
Effects of Allergic Inflammation on TLR2 Signaling and Mycoplasma Infection$390,000
R01 · FY2009 · AI · contact PI
SPLUNC1 protein in host defense against Mycoplasma pneumoniae infection$390,000
R01 · FY2009 · HL · contact PI
SPLUNC1 protein in host defense against Mycoplasma pneumoniae infection$253,636
R01 · FY2009 · HL · contact PI
CORE--Histopathology and Microbiology$589,522
P01 · FY2008 · HL · contact PI
Effects of Allergic Inflammation on TLR2 Signaling and Mycoplasma Infection$390,000
R01 · FY2008 · AI · contact PI
CORE--Histopathology and Microbiology$584,152
P01 · FY2007 · HL · contact PI
CORE--Histopathology and Microbiology$406,505
P01 · FY2006 · HL · contact PI
CORE--Histopathology and Microbiology$394,664
P01 · FY2005 · HL
CORE--Histopathology and Microbiology$383,170
P01 · FY2004 · HL